Anixa Biosciences Inc Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Anixa Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Anixa Biosciences Inc Operating Income (Loss) for the quarter ending October 31, 2024 was -$3.16M, a 3.67% decline year-over-year.
  • Anixa Biosciences Inc Operating Income (Loss) for the twelve months ending October 31, 2024 was -$13.8M, a 25.6% decline year-over-year.
  • Anixa Biosciences Inc annual Operating Income (Loss) for 2024 was -$13.8M, a 25.6% decline from 2023.
  • Anixa Biosciences Inc annual Operating Income (Loss) for 2023 was -$11M, a 20.6% increase from 2022.
  • Anixa Biosciences Inc annual Operating Income (Loss) for 2022 was -$13.9M, a 5.63% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$13.8M -$3.16M -$112K -3.67% Aug 1, 2024 Oct 31, 2024 10-K 2025-01-10
Q2 2024 -$13.7M -$3.59M -$748K -26.3% May 1, 2024 Jul 31, 2024 10-Q 2024-09-06
Q1 2024 -$13M -$3.47M -$907K -35.4% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-04
Q4 2023 -$12.1M -$3.61M -$1.05M -41.2% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-12
Q3 2023 -$11M -$3.05M +$558K +15.5% Aug 1, 2023 Oct 31, 2023 10-K 2025-01-10
Q2 2023 -$11.6M -$2.84M -$47K -1.68% May 1, 2023 Jul 31, 2023 10-Q 2024-09-06
Q1 2023 -$11.5M -$2.56M +$1.03M +28.7% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-04
Q4 2022 -$12.6M -$2.56M +$1.32M +34.1% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-12
Q3 2022 -$13.9M -$3.61M +$469K +11.5% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-16
Q2 2022 -$14.3M -$2.8M +$1.59M +36.3% May 1, 2022 Jul 31, 2022 10-Q 2023-09-06
Q1 2022 -$15.9M -$3.59M -$1.15M -47.3% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$14.8M -$3.88M -$1.65M -73.8% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$13.1M -$4.08M -$1.84M -81.9% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-04
Q2 2021 -$11.3M -$4.39M -$1.95M -80.1% May 1, 2021 Jul 31, 2021 10-Q 2022-09-09
Q1 2021 -$9.35M -$2.44M +$233K +8.73% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-10
Q4 2020 -$9.58M -$2.23M +$397K +15.1% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-11
Q3 2020 -$9.98M -$2.24M -$114K -5.34% Aug 1, 2020 Oct 31, 2020 10-K 2022-01-04
Q2 2020 -$9.86M -$2.44M -$252K -11.5% May 1, 2020 Jul 31, 2020 10-Q 2021-09-01
Q1 2020 -$9.61M -$2.67M -$76.9K -2.97% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-10
Q4 2019 -$9.54M -$2.63M +$2.35M +47.2% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q3 2019 -$11.9M -$2.13M +$3.28M +60.6% Aug 1, 2019 Oct 31, 2019 10-K 2021-01-07
Q2 2019 -$15.2M -$2.18M +$3.42M +61% May 1, 2019 Jul 31, 2019 10-Q 2020-09-08
Q1 2019 -$18.6M -$2.59M -$1.19M -85.1% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q4 2018 -$17.4M -$4.98M -$3.11M -166% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-09
Q3 2018 -$14.3M -$5.41M -$3.67M -211% Aug 1, 2018 Oct 31, 2018 10-K 2020-01-09
Q2 2018 -$10.6M -$5.61M -$3.87M -224% May 1, 2018 Jul 31, 2018 10-Q 2019-09-06
Q1 2018 -$6.74M -$1.4M -$189K -15.6% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-12
Q4 2017 -$6.56M -$1.87M -$480K -34.4% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-13
Q3 2017 -$6.08M -$1.74M -$824K -90.3% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-11
Q2 2017 -$5.25M -$1.73M -$756K -77.6% May 1, 2017 Jul 31, 2017 10-Q 2018-09-07
Q1 2017 -$4.5M -$1.21M -$63.6K -5.54% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-11
Q4 2016 -$4.43M -$1.39M +$77.5K +5.26% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-09
Q3 2016 -$4.51M -$913K +$264K +22.4% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-09
Q2 2016 -$4.77M -$975K +$516K +34.6% May 1, 2016 Jul 31, 2016 10-Q 2017-09-08
Q1 2016 -$5.29M -$1.15M +$985K +46.2% Feb 1, 2016 Apr 30, 2016 10-Q 2017-05-26
Q4 2015 -$6.27M -$1.47M -$5.33M -138% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-16
Q3 2015 -$945K -$1.18M +$387K +24.7% Aug 1, 2015 Oct 31, 2015 10-K/A 2016-12-08
Q2 2015 -$1.33M -$1.49M -$1.33M -834% May 1, 2015 Jul 31, 2015 10-Q 2016-08-19
Q1 2015 -$565 -$2.13M -$778K -57.4% Feb 1, 2015 Apr 30, 2015 10-Q 2016-05-20
Q4 2014 $777K $3.86M +$5.82M Nov 1, 2014 Jan 31, 2015 10-Q 2016-02-19
Q3 2014 -$5.04M -$1.56M +$211K +11.9% Aug 1, 2014 Oct 31, 2014 10-K 2015-12-23
Q2 2014 -$5.25M -$160K +$2.06M +92.8% May 1, 2014 Jul 31, 2014 10-Q 2015-08-18
Q1 2014 -$7.31M -$1.36M +$496K +26.8% Feb 1, 2014 Apr 30, 2014 10-Q 2015-05-22
Q4 2013 -$7.81M -$1.96M +$108K +5.21% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-09
Q3 2013 -$7.92M -$1.78M -$49.5K -2.87% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 -$7.87M -$2.22M -$1.58M -245% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 -$6.29M -$1.85M -$973K -111% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 -$5.32M -$2.07M -$1.19M -134% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$4.13M -$1.73M -$719K -71.4% Aug 1, 2012 Oct 31, 2012 10-K/A 2014-01-17
Q2 2012 -$3.42M -$643K +$564K +46.7% May 1, 2012 Jul 31, 2012 10-Q/A 2013-09-20
Q1 2012 -$3.98M -$878K +$409K +31.8% Feb 1, 2012 Apr 30, 2012 10-Q/A 2013-06-19
Q4 2011 -$4.39M -$887K +$639K +41.9% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q3 2011 -$5.03M -$1.01M Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 -$1.21M +$62.6K +4.93% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 -$1.29M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$1.53M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 -$1.27M May 1, 2010 Jul 31, 2010 10-Q/A 2011-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.